|
| CABG with myoclonus N: 338 | CABG without myoclonus N: 786,000 | P value |
| Age (mean ± SD) | 65.2 ± 14.4 | 66.1 ± 10.6 | 0.50 |
| Age ≥65 yrs | 190 (56.2%) | 453,855 (57.7%) | 0.79 |
| Female | 77 (23.0%) | 210,623 (26.8%) | 0.45 |
| Medical Comorbidities |
|
|
|
| Diabetes Mellitus | 153 (45.3%) | 338,597 (43.1%) | 0.70 |
| Congestive Heart Failure | 0 | 9619 (1.22%) | - |
| Hypertension | 264 (78.0%) | 623,500 (79.3%) | 0.79 |
| Hyperlipidemia | 168 (49.6%) | 497,390 (63.3%) | 0.03 |
| Atrial Fibrillation | 131 (38.8%) | 262,069 (33.3%) | 0.36 |
| Renal Failure | 96 (28.4%) | 125,667 (15.9%) | 0.03 |
| Hypercoagulable State | 103 (30.6%) | 157,019 (20.0%) | 0.05 |
| Chronic Lung Disease | 84 (0.24%) | 176,121 (22.4%) | 0.64 |
| In-hospital complications |
|
|
|
| Acute Kidney Injury | 132 (39.1%) | 147,998 (18.8%) | 0.001 |
| Myocardial Infarction | 142 (42.0%) | 237,641 (30.2%) | 0.05 |
| Pneumonia | 40 (11.8%) | 37,105 (4.72%) | 0.08 |
| Urinary Tract Infection | 28 (8.41%) | 53,923 (6.86%) | 0.64 |
| Sepsis | 18 (5.55%) | 18,369 (2.33%) | 0.24 |
| Outcomes |
|
|
|
| Prolonged length of stay | 275 (81.2%) | 515,605 (65.6%) | 0.001 |
| Discharge disposition of alive patients to nursing home | 128 (43.4%) | 168,470 (22.0%) | 0.002 |
| In-hospital mortality | 41 (12.3%) | 19,298 (2.45%) | 0.02 |